The arrival of Retatrutide ZPHC, at a strength of 120mg, is creating considerable buzz within the medical community. This novel dual GIP and GLP-1 receptor medication appears to offer impressive improvements in body reduction compared to current therapies. Initial clinical studies have indicated significant decreases in weight , possibly representi